South Dakota Investment Council’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,322
Closed -$66K 591
2021
Q3
$66K Sell
1,322
-20,800
-94% -$1.26M ﹤0.01% 573
2021
Q2
$1.39M Hold
22,122
0.02% 408
2021
Q1
$2.06M Hold
22,122
0.03% 352
2020
Q4
$1.98M Buy
22,122
+1,400
+7% +$128K 0.04% 332
2020
Q3
$2.14M Sell
20,722
-8,370
-29% -$902K 0.05% 297
2020
Q2
$2.3M Hold
29,092
0.05% 274
2020
Q1
$1.68M Sell
29,092
-28
-0.1% -$1.61K 0.05% 287
2019
Q4
$1.57M Buy
29,120
+1,040
+4% +$56.4K 0.03% 351
2019
Q3
$1.47M Buy
28,080
+18,380
+189% +$856K 0.03% 396
2019
Q2
$469K Buy
9,700
+1,700
+21% +$81.5K 0.01% 513
2019
Q1
$404K Hold
8,000
0.01% 519
2018
Q4
$474K Hold
8,000
0.01% 482
2018
Q3
$527K Buy
+8,000
New +$467K 0.01% 501
2015
Q4
Sell
-12,100
Closed -$345K 546
2015
Q3
$345K Sell
12,100
-9,400
-44% -$310K 0.01% 466
2015
Q2
$708K Sell
21,500
-35,300
-62% -$1.09M 0.01% 415
2015
Q1
$1.63M Hold
56,800
0.03% 317
2014
Q4
$1.55M Hold
56,800
0.03% 308
2014
Q3
$1.21M Buy
+56,800
New +$1.3M 0.02% 333

Other funds holding EBS

South Dakota Investment Council's EBS Position: Q4 2021 in Review

South Dakota Investment Council sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 1,322 shares — an estimated $66K sold.

South Dakota Investment Council first reported a position in EBS in Q3 2014 and held it in 18 quarters. The position peaked at $2.3M in Q2 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • South Dakota Investment Council reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 1,322 Emergent Biosolutions shares in Q4 2021, an estimated $66K.
  • South Dakota Investment Council first reported a position in Emergent Biosolutions in Q3 2014 and held it in 18 quarters.
  • South Dakota Investment Council's Emergent Biosolutions position peaked at $2.3M in Q2 2020.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on South Dakota Investment Council's 13F filing for Q4 2021, filed 8 Feb 2022.